SEC Company Response from CONOR MEDSYSTEMS INC (CIK 0001108271) — Dec 10, 2004
CONOR MEDSYSTEMS INC (CIK 0001108271)
Date: Dec. 10, 2004 · CIK: 0001108271 · Accession: 0001193125-04-211180
AI Filing Summary & Sentiment
File numbers found in text: 333-119174
Letter
Acceleration Request
[Conor Medsystems Letterhead]
December 10, 2004
VIA FACSIMILE
Securities and Exchange Commission
Division of Corporation Finance
450 Fifth Street, N.W.
Washington, DC 20549
Re:
Conor Medsystems, Inc.
Registration Statement on Form S-1 (File No. 333-119174)
Ladies and Gentlemen:
The undersigned registrant hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 (the “Filing”) to become effective at 2:30 p.m. Eastern Time on December 13, 2004, or as soon thereafter as is practicable.
In connection with this request, the undersigned registrant hereby acknowledges that:
(i) should the Commission or the staff of the Commission (the “Staff”), acting pursuant to delegated authority, declare the Filing effective, it does not foreclose the Commission from taking any action with respect to the Filing;
(ii) the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Filing effective, does not relieve the undersigned registrant from its full responsibility for the adequacy and the accuracy of the disclosure in the Filing; and
(iii) the undersigned registrant may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
CONOR MEDSYSTEMS, INC.
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request [Conor Medsystems Letterhead] December 10, 2004 VIA FACSIMILE Securities and Exchange Commission Division of Corporation Finance 450 Fifth Street, N.W. Washington, DC 20549 Re: Conor Medsystems, Inc. Registration Statement on Form S-1 (File No. 333-119174) Ladies and Gentlemen: The undersigned registrant hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 (the “Filing”) to become effective at 2:30 p.m. Eastern Time on December 13, 2004, or as soon thereafter as is practicable. In connection with this request, the undersigned registrant hereby acknowledges that: (i) should the Commission or the staff of the Commission (the “Staff”), acting pursuant to delegated authority, declare the Filing effective, it does not foreclose the Commission from taking any action with respect to the Filing; (ii) the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Filing effective, does not relieve the undersigned registrant from its full responsibility for the adequacy and the accuracy of the disclosure in the Filing; and (iii) the undersigned registrant may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Very truly yours, CONOR MEDSYSTEMS, INC. By /s/ FRANK LITVACK, M.D. Frank Litvack, M.D. Chief Executive Officer and Chairman of the Board cc: Michael Giaquinto Suzanne S. Hooper, Esq. John T. McKenna, Esq.